Executive Vice President and co-founder Iya Khalil will moderate a panel featuring Anmol Madan of Ginger.io, Julie Yoo of Kyruus and David Steinberg of PureTech Ventures at the Convergence Forum East in Chatham, MA on Saturday, May 19th.…
News & Events
What Did You Know, and When Did You Stop Knowing It?
Read CEO Colin Hill’s Healthcare 2020 blog post “What Did You Know, and When Did You Stop Knowing It?” on Forbes.com.…
Check the Pulse of Biotech IT in Boston
Executive Vice President and co-founder Iya Khalil featured in FierceBiotechIT.…
Sage Bionetworks Commons Congress
Executive Vice President and co-founder Iya Khalil will speak at the Sage Bionetworks Congress Unplugged! in San Francisco on Friday, April 20th.…
Cambia Health Solutions Announces Investment in GNS Healthcare
Partnership in Big Data Analytics will help personalize care plans and reduce healthcare costs
PORTLAND, Ore., April 18, 2012 - Does electronic health data hold the key to improved health and consumer affordability? Cambia Health Solutions and GNS Healthcare think so. Cambia has invested in GNS Healthcare as they advance their technologies – which can understand and rapidly interpret massive volumes of complex health data – and plans to use it in ways that benefit their members.
GNS’ Reverse Engineering Forward Simulation …
In God We Trust, All Others Bring Evidence
Read CEO Colin Hill‘s Healthcare 2020 blog post “In God We Trust, All Others Bring Evidence” on Forbes.com.…
Using Big Data to Find Cause and Effect
Coverage in Health 2.0 News of our collaboration with UCSF using REFS™ to uncover novel signaling networks that slow the proliferation of breast cancer cells.…
Results of GNS Healthcare Collaborations with UCSF, NCI Presented at AACR Annual Meeting in Chicago
Novel biological mechanisms in cancer discovered by REFS™ supercomputer analytics platform and validated experimentally
CHICAGO, April 4, 2012 – Results from two GNS Healthcare collaborations were presented this week at the American Association for Cancer Research (AACR) Annual Meeting in Chicago. In each, GNS researchers used supercomputer-powered data analytics to discover novel biological mechanisms in cancer. The predictions made using this computational approach were then validated experimentally.
In the first collaboration, the results of which were presented in a talk Sunday…
American Association for Cancer Research Annual Meeting
Results from two GNS collaborations will be presented at the 2012 AACR Annual Meeting in Chicago. The first presentation, a talk on Sunday, April 1, will highlight GNS’s collaboration with Dr. W. Michael Korn’s laboratory at UC San Francisco. The second, a poster presentation on Wednesday, April 4, will highlight GNS’s collaboration with the laboratory of Dr. James Doroshow, Director of the Division of Cancer Treatment and Diagnosis at the National Cancer Institute.…
Iya Khalil, Eric Schadt Named to “Top 10 Biotech Techies” List
EVP and co-founder Iya Khalil and Scientific Advisory Board Member Eric Schadt were selected by FierceBiotech IT as two of Biotech’s Top 10 “Techies,” innovators who are “challenging the status quo in their respective fields–with computer-based tools playing central roles in their endeavors.” Also named to the list were the CSIR’s Samir Brahmachari, Stanford’s Atul Butte, UW’s Seth Cooper, Medidata’s Glen de Vries, the Institute for Systems Biology’s Leroy Hood, Pfizer’s Jeffrey Keisling, The …